FilingSEC EDGAR8-K
AEON Biopharma Releases Corporate Presentation
· SEC accepted
StageCorporate Presentation
Filing content
The company made available a corporate presentation detailing its development strategy, market opportunities, and upcoming clinical milestones for ABP-450.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…